BarbaraSpitzerMD
Pediatric Hematology & Oncology • Hackensack, NJSection Chief, Pediatric Stem Cell Transplant and Cellular Therapy
Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Hackensack Meridian Health, Joseph M. Sanzari Children's Hospital
30 Prospect Ave
Hackensack, NJ 07601Phone+1 551-996-5600
Summary
- Stem cell transplant
Primary immune deficiencies
Myeloid disease
Clonal hematopoiesis
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
New York University School of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2011 - 2026
NJ State Medical License 2023 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 344 citationsCancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L. Bolton, Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin
Nature Genetics. 2020-10-26 - 117 citationsDose-dependent role of the cohesin complex in normal and malignant hematopoiesisAaron D. Viny, Christopher J. Ott, Barbara Spitzer, Martín A. Rivas, Cem Meydan
The Journal of Experimental Medicine. 2015-10-19 - 52 citationsDnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsOlga A. Guryanova, Yen K. Lieu, Francine E. Garrett-Bakelman, Barbara Spitzer, Jacob L. Glass
Leukemia. 2016-05-01
Abstracts/Posters
- Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALLBarbara Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- De Novo Myelodysplastic Syndromes in Patients 20-50 Years Old Characterized By Frequent Mutations in TP53 and Transcription-Related GenesBarbara Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
